Monday, June 22, 2026 | 08:39 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma Ltd

Board Meeting Intimation for Considering The Un-Audited Financial Results For The Quarter Ended 30Th June 2025 And Declaration Of Interim Dividend For The FY25-26

04:00 PM, 4th Aug 2025

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-audited Financial Results for the quarter ended 30th June 2025 and declaration of Interim Dividend for the FY25-26

More Natco Pharma Ltd Announcements